Biological Information
Background Information:
STK32A (Serine/Threonine Kinase 32A) is a serine/threonine protein kinase that is expressed in a variety of tissues, including the brain, liver, and heart. STK32A has been implicated in the regulation of several cellular processes, including cell proliferation, cell survival, and autophagy. Research has suggested that STK32A may play a role in the development and progression of cancer. STK32A has been shown to be overexpressed in several types of cancer, including lung cancer, breast cancer, and ovarian cancer, and high levels of STK32A expression have been associated with poor prognosis. Additionally, STK32A has been suggested as a potential therapeutic target in cancer, and efforts to develop small-molecule inhibitors of the kinase are underway.
Target Class:
Kinase
Family:
AGC
Sub Family:
Protein Ser/Thr
Protein Name:
YANK1
Protein Aliases:
Yet another novel kinase 1
Accession Number:
NM_001112724.1
UniProt Number:
Q8WU08
Gene Name:
STK32A
Gene ID:
202374
Gene Aliases:
MGC22688|YANK1
Target Species:
Human
Usage
Product Type:
Enzymes
Application:
Drug Discovery & Development
Storage Conditions:
1 year at -70°C
Usage disclaimer:
These products may be covered by issued US and/or foreign patents, patent applications and subject to a Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information.
Assay Information
Assay Type:
Enzymatic
Bioassay Data
Trademark Statement:
For Research Use Only